KPNB1 overexpression has been reported in several cancers including comorbidities we identified with significant genes and pathways (breast cancer, colorectal cancer, lung cancer, ovarian cancer, and prostate cancer) [71,72,73,74,75]. Here, KPNB1 is linked to lung cancer.